Do not use in cases of known hypersensitivity to the active ingredient.
Special warnings
Do not use in horses with known cardiac disease.
Special precautions for use
Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This veterinary medicinal product contains clenbuterol, a beta-agonist.
Take care to avoid skin contact. In case of accidental skin contact, wash affected area thoroughly. If irritation occurs/persists seek medical advice. Take care to avoid accidental eye contact. In the case of accidental eye contact, flush thoroughly with clean water and seek medical advice and show the package leaflet or the label to the physician.
Take care to avoid eye contact. In the case of accidental eye contact, flush thoroughly with clean water and seek medical advice and show the package leaflet or the label to the physician.
Do not eat, drink or smoke when using the product.
Wash hands thoroughly after using the product.
People with known hypersensitivity to clenbuterol should avoid contact with the veterinary medicinal product.
Special precautions for the protection of the environment:
Not applicable.
Adverse events
Horses:
Rare (1 to 10 animals / 10,000 animals treated): | Restlessness1, Hypotension1,2, Tachycardia, Muscle tremor1, Increased sweating1, 3 |
1Typical for beta-agonists
2Slight
3Mainly neck region
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Use during pregnancy, lactation or lay
If used during pregnancy, treatment must be discontinued at the expected time of delivery, since uterine contractions may be abolished under its influence.
Interaction with other medicinal products and other forms of interaction
The veterinary medicinal antagonises the effects of prostaglandin F2-alpha and oxytocin.
The veterinary medicinal is antagonised by symbol 98 \f "Symbol" \s 10<<-adrenergic blocking agents.
Symptoms of overdose (and where applicable, emergency procedures and antidotes)
Dosages of clenbuterol hydrochloride up to 4 times the therapeutic dose (administered orally) for a period of 90 days caused transient side effects typical for beta2-adrenoceptor agonists (sweating, tachycardia, muscle tremor), which required no treatment.
In case of accidental overdose, a symbol 98 \f "Symbol" \s 10<<-blocker (such as propranolol) may be used as antidote.
Withdrawal period
Meat and offal: 28 days.
Not authorised for use in animals producing milk for human consumption.